Autonomix Medical Inc. (AMIX)
AMIX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1617867/000143774926018573/0001437749-26-018573-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2026-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | AMIX on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001617867 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$16.7M |
| Operating income | -$17.0M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $7.0M |
| Total assets | $7.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued." | 10-Q 2026-11-10 |
| Cash and burn | $7.7M cash; operating cash flow -$3.0M a quarter. | Report 2026-09-30 |
| Shares outstanding | 2,045,193 (2026-11-06); 6,886,648 a year earlier; 18,793,974 three years earlier. 1y figure adjusted for splits (1-for-21 overall); 3y figure adjusted for splits (1-for-420 overall). | Cover page 2026-11-06 |
| Reverse splits, 3 years | 2; latest 1-for-21 on 2026-06-24 | Source 2026-06-24 |
| Shelf and offerings, 12 months | 3 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-09-11 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-01-16 |
| Auditor | Forvis Mazars, LLP, Atlanta, Georgia, United States | PCAOB Form AP 2026-06-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-09-30 | $0 | -$3.1M | -$2.6M | $7.7M | No debt tags | $0 | 10-Q 2026-11-10 |
| Q1 2027 2026-06-30 | $0 | -$2.7M | -$3.5M | $3.5M | No debt tags | $0 | 10-Q 2026-08-13 |
| Q4 2026 2026-03-31 | $0 | -$2.7M | -$2.9M | $7.0M | No debt tags | $0 | 10-K 2026-05-27 |
| Q3 2026 2025-12-31 | $0 | -$3.3M | -$3.0M | $9.9M | No debt tags | $0 | 10-Q 2026-02-11 |
| Q2 2026 2025-09-30 | $0 | -$7.5M | -$3.8M | $7.5M | No debt tags | $0 | 10-Q 2026-11-10 |
| Q1 2026 2025-06-30 | $0 | -$3.3M | -$2.6M | $8.6M | No debt tags | $0 | 10-Q 2026-08-13 |
| Q4 2025 2025-03-31 | $0 | -$11.4M | -$8.3M | $9.1M | No debt tags | $0 | 10-K 2026-05-27 |
| Q3 2025 2024-12-31 | $0 | -$2.7M | -$2.3M | $11.8M | $1.1M | $0 | 10-Q 2026-02-11 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2026-09-16 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-06-15 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-10 |
| Latest current report FORM 8-K | 8-K | 2026-11-03 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-09-14 |
Source: SEC EDGAR submissions feed, 150 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -9.9% |
| 1 month | -54.5% |
| 3 months | -80.0% |
| Year to date | -88.1% |
| 1 year | -91.1% |
| From 52-week high | -94.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CODX | Co-Diagnostics Inc. | $0.2249 | -13.03% | $2.4M |
| BJDX | Bluejay Diagnostics Inc. | $2.29 | -12.26% | $2.6M |
| ICCM | IceCure Medical Ltd. | $0.7601 | +4.12% | $2.6M |
| NXGL | NexGel Inc | $3.93 | +2.08% | $1.9M |
| IVF | INVO Fertility Inc. | $2.40 | -7.69% | $2.8M |
| VVOS | Vivos Therapeutics Inc. | $0.0822 | -16.12% | $2.8M |
| XAIR | Beyond Air Inc. | $2.02 | -5.16% | $3.4M |
| TNON | Tenon Medical Inc. | $1.33 | -5.32% | $3.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier